Featured News
545Wire StoriesONE Championship Welcomes Stage Front VIP as Global VIP Experience Partner
Experiences for ONE’s U.S. Debut in 2023 to be Announced in Near Future SINGAPORE–(BUSINESS WIRE)–ONE Championship™ (ONE), the world’s largest martial arts...
- 576Wire Stories
ONE Championship Welcomes Stage Front VIP as Global VIP Experience Partner
Experiences for ONE’s U.S. Debut in 2023 to be Announced in Near Future SINGAPORE–(BUSINESS WIRE)–ONE Championship™ (ONE), the world’s largest martial arts...
- 456Wire Stories
Looking for a holiday gift? Choose Rokid Air and feel the thrill of carrying a big screen in your pocket
HANGZHOU, China–(BUSINESS WIRE)–The holiday season is back! How do you get your favorite entertainment whenever, wherever? During the holidays, augmented reality glasses...
- 626Wire Stories
Datopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials
Daiichi Sankyo and AstraZeneca’s TROP2 directed ADC showed an encouraging objective response rate of 32% and a manageable safety profile in patients...
- 666Wire Stories
Datopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials
Daiichi Sankyo and AstraZeneca’s TROP2 directed ADC showed an encouraging objective response rate of 32% and a manageable safety profile in patients...
- 612Wire Stories
Takeda to Present Data at 64th American Society of Hematology (ASH) Annual Meeting, Demonstrating Commitment to Patients with Hematologic Cancers and Other Blood Diseases
? Company to Feature 15 Company-Sponsored and Nine Collaborative Abstracts in Oncology and Hematology ? Oral Presentations Include Updated Results from Phase...
- 645Wire Stories
Azura Ophthalmics Presents Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunction at Ophthalmology Innovation Summit XII
TEL AVIV, Israel & MELBOURNE, Australia–(BUSINESS WIRE)–Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for...
- 543Wire Stories
Inside information: Sievi Capital’s target company Nordic Rescue Group’s subsidiary ceases the manufacturing of rescue lifts
Sievi Capital Plc Inside information 9 December 2022 at 2:00 pm EET Inside information: Sievi Capital’s target company Nordic Rescue Group’s subsidiary...
- 442Wire Stories
BeiGene Calls for Greater Integration of Mental Health in Cancer Care After New Survey Reveals Gaps/Barriers for Patients and Survivors
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$BGNE #BeiGene–BeiGene, a global biotechnology company, is convening diverse stakeholders to amplify the mental health...
- 479Wire Stories
India Telecoms Industry Report and Database 2022: Market Sizing, Forecasts, Insights, Key Telecom Trends, 5G, Digital Infrastructure 2023-2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Telecoms Industry Report – 2023-2028” report has been added to ResearchAndMarkets.com’s offering. Globally, the telecommunications sector is proving to...
- 687Wire Stories
BiomeBank Continues Growth Trajectory With Over $10M Capital Raise
Following last month’s regulatory approval, BiomeBank announces a successful capital raise of $10.65 million AUD Funding will be used to scale up...
